Dopamine-agonist combination therapy with sedatives for improving sleep quality

Details for Australian Patent Application No. 2005215376 (hide)

Owner Sunovion Pharmaceuticals Inc.

Inventors Barberich, Timothy J.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005215376

PCT Pub. Number WO2005/079851

Priority 60/545,413 18.02.04 US

Filing date 7 February 2005

Wipo publication date 1 September 2005

Acceptance publication date 20 January 2011

International Classifications

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

Event Publications

14 September 2006 PCT application entered the National Phase

  PCT publication WO2005/079851 Priority application(s): WO2005/079851

25 January 2007 Change of Name(s) of Applicant(s), Section 104

  Sepracor, Inc. The name of the applicant has been changed to Sepracor Inc.

20 January 2011 Application Accepted

  Published as AU-B-2005215376

19 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005215377-Polar-modified bonded phase materials for chromatographic separations

2005215375-System and method for testing a clamping force